MCID: PLY018
MIFTS: 61

Polycythemia malady

Summaries for Polycythemia

About this section
Sources:
63Wikipedia, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:63 Polycythemia (also known as polycythaemia or polyglobulia) is a disease state in which the proportion of... more...

MalaCards: Polycythemia, also known as polycythemia, nos, is related to polycythemia vera and primary polycythemia. An important gene associated with Polycythemia is CD177 (CD177 molecule), and among its related pathways are Akt Signaling and Jak-STAT signaling pathway. The compounds tyrosine and vegf have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, bone and myeloid, and related mouse phenotypes are hematopoietic system and immune system.

Aliases & Classifications for Polycythemia

About this section
Sources:
8Disease Ontology, 10DISEASES, 44Novoseek, 60UMLS, 34MeSH, 56SNOMED-CT, 39NCIt
See all sources

Aliases & Descriptions:

polycythemia 8 10 44 60
polycythemia, nos 8
erythrocythemia 8
polycythaemia 8


External Ids:

Disease Ontology8 DOID:8432
MeSH34 D011086
NCIt39 C26863

Related Diseases for Polycythemia

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Primary Polycythemia family:

Polycythemia Due to Hypoxia Acquired Polycythemia
polycythemia

Diseases related to Polycythemia via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 304)
idRelated DiseaseScoreTop Affiliating Genes
1polycythemia vera31.8TIMP1, EPO, EPOR, PF4, IL3, KITLG
2primary polycythemia31.0VHL, JAK2, STAT5A, EPO, EPOR
3myelofibrosis31.0THPO, EPO, JAK2
4leukemia30.8CD177, MPL, ITGB3, EPOR, PF4, EPO
5thrombocytosis30.5IFNA2, PPBP, JAK2, MPL, CD177, EPO
6acquired polycythemia30.4EPO, JAK2, EPOR
7myeloid leukemia30.4SOCS3, JAK2, MPL, IL3, KITLG, STAT5A
8hypertension30.4PPBP
9hemangioblastoma30.3VHL, EPOR, EPO
10acute leukemia30.3EPO, MPL, STAT5A, EPOR, PTPN6, ACP1
11chronic myeloid leukemia30.3EPO, CD177, MPL, ITGB3, STAT5A, JAK2
12hepatitis30.2IFNA2
13erythrocytosis30.2VHL, JAK2, MPL, CD177, EPO, EPOR
14thrombocytopenia30.1PF4, KITLG, EPO, MPL, THPO, IL3
15myocardial infarction30.1PPBP, ITGB3, PF4
16ischemia30.0PF4, SOCS3, JAK2, EPOR
17pancreatitis30.0KITLG
18myeloma29.9IFNA2, JAK2, STAT5A, EPO, EPOR, PF4
19hepatocellular carcinoma29.9EPOR, PPBP, SOCS3, IFNA2, TIMP1, ACP1
20acute myocardial infarction29.9PF4, KITLG, PPBP
21vascular disease29.9PF4, JAK2, TIMP1
22vasculitis29.9IFNA2, PPBP
23glomerulonephritis29.9EPOR
24thrombophilia29.9PPBP, PF4
25hemorrhagic thrombocythemia29.9CD177
26antiphospholipid syndrome29.9PF4
27megakaryocytic leukemia29.8THPO, IL3, PF4, EPOR
28nephrotic syndrome29.8PPBP
29deficiency anemia29.7PPBP, G6PD, IFNA2, TIMP1, JAK2, MPL
30adenocarcinoma29.7PTPN6, ACP1, KITLG, PF4, EPOR, STAT5A
31atherosclerosis29.7PPBP, ITGB3, PF4, ACP1, SOCS3, TIMP1
32sarcoma29.7ACP1, THPO, KITLG, JAK2
33chronic myeloproliferative disease29.7THPO, MPL, JAK2
34pancytopenia29.7THPO, MPL, EPO, IL3
35hepatitis c29.7SOCS3, THPO, TIMP1, IFNA2
36purpura29.7THPO
37disseminated intravascular coagulation29.7THPO, PF4, PPBP
38tuberculosis29.7ACP1, PF4
39portal vein thrombosis29.7THPO
40eosinophilia29.7IFNA2, JAK2, IL3
41hemangioma29.7VHL, IFNA2
42congestive heart failure29.7EPO, EPOR, PPBP
43neurofibromatosis29.7VHL
44renal clear cell carcinoma29.7VHL, EPOR
45hypersplenism29.7THPO
46hemoglobinopathy29.7G6PD, EPO
47erythropoietin polycythemia10.6
48hypermanganesemia with dystonia polycythemia and cirrhosis10.4
49stress polycythemia10.3
50cerebritis10.3

Graphical network of the top 20 diseases related to Polycythemia:



Diseases related to polycythemia

Clinical Features for Polycythemia

About this section

Drugs & Therapeutics for Polycythemia

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Polycythemia

Drug clinical trials:

Search ClinicalTrials for Polycythemia

Search NIH Clinical Center for Polycythemia

Search CenterWatch for Polycythemia

Genetic Tests for Polycythemia

About this section

Anatomical Context for Polycythemia

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Polycythemia:

32
Bone marrow, Bone, Myeloid, Endothelial, Liver, Testes, Lung, Heart, T cells, B cells, Kidney, Fetal brain, Monocytes, Testis, Prostate, Placenta, Skin, Spinal cord, Cerebellum, Cortex, Brain, Spleen, Whole blood, Adrenal cortex

Animal Models for Polycythemia or affiliated genes

About this section
Sources:
36MGI
See all sources

Publications for Polycythemia

About this section
Sources:
50PubMed
See all sources

Articles related to Polycythemia:

(show top 50)    (show all 898)
idTitleAuthorsYear
1
Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T-cells and granulocytes. (24413320)
2014
2
Macrophages support pathological erythropoiesis in polycythemia vera and I^-thalassemia. (23502961)
2013
3
Severe delayed postpolypectomy bleeding in elder patient with post-polycythemia myelofibrosis. (24267952)
2013
4
MicroRNA expression and JAK2 allele burden in bone marrow trephine biopsies of polycythemia vera, essential thrombocythemia and early primary myelofibrosis. (23343777)
2013
5
A classification system based on a new wrapper feature selection algorithm for the diagnosis of primary and secondary polycythemia. (24290929)
2013
6
Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway. (23677251)
2013
7
Emerging drugs for polycythemia vera. (23968379)
2013
8
Treatment target in polycythemia vera. (23599949)
2013
9
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-I+ in a murine model of polycythemia vera. (23487027)
2013
10
Concurrent polycythemia vera and chronic lymphocytic leukemia: treatment response to pegylated interferon alpha 2a. (23553722)
2013
11
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. (23739289)
2013
12
Hemichorea, a rare presenting feature of polycythemia vera. (23466854)
2013
13
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. (22331582)
2012
14
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia. (23121980)
2012
15
Persistent neutrophilia progressing to polycythemia vera. (21934254)
2011
16
Idiopathic thrombocytopenic purpura coexisting with polycythemia vera. (21897612)
2011
17
Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. (21705500)
2011
18
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F. (20601445)
2010
19
The development of gastric cancer in a patient with polycythemia Vera, 3P deletion, and JAK2 V617F mutation. (20306156)
2010
20
Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. (20008298)
2010
21
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. (20052743)
2010
22
Polycythemia and elevated serum erythropoietin associated with a liver haemangioma. (20980114)
2010
23
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. (20508616)
2010
24
Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. (20091569)
2010
25
Polycythemia vera presenting with bilateral papilledema. (19574711)
2009
26
Free tissue transfer in a head and neck cancer patient with polycythemia vera. (19568061)
2009
27
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. (19295546)
2009
28
Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera. (18481066)
2008
29
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. (18268279)
2008
30
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis. (18187660)
2008
31
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. (18768782)
2008
32
Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation. (18223282)
2008
33
Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China. (19002391)
2008
34
Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia. (18519514)
2008
35
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. (17625606)
2007
36
Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia. (17640059)
2007
37
Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations. (17204324)
2007
38
Is congenital secondary erythrocytosis/polycythemia caused by activating mutations within the HIF-2 alpha iron-responsive element? (17881647)
2007
39
Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia. (20425334)
2006
40
Myths & facts...about polycythemia vera. (15879946)
2005
41
Challenging manifestations of malignancies. Case 1. Polycythemia and high serum erythropoietin level as a result of hemangioblastoma. (15337812)
2004
42
Characterization of blood vessels in bone marrow from patients with chronic myeloid leukemia and polycythemia vera. (15513321)
2004
43
Budd-Chiari syndrome with fatal outcome in a patient with polycythemia vera and antiphospholipid antibody syndrome]. (15529946)
2004
44
Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene. (11158582)
2001
45
Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. (1991825)
1991
46
Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. (2227815)
1990
47
Malignant histiocytosis occurring with acute myelogenous leukemia in a patient with longstanding polycythemia vera. (3466664)
1987
48
Acute necrotizing encephalitis. Report of a case associated with polycythemia vera. (5640195)
1968
49
The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoiesis stimulating factor by the tumor. (13782653)
1961
50
Radioactive phosphorus in the treatment of primary polycythemia (vera). (13359507)
1956

Genetic Variations for Polycythemia

About this section

Expression for genes affiliated with Polycythemia

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Polycythemia

Search GEO for disease gene expression data for Polycythemia.

Pathways for genes affiliated with Polycythemia

About this section
Sources:
51QIAGEN, 29KEGG, 53Reactome, 37NCBI BioSystems Database, 12EMD Millipore, 4Cell Signaling Technology, 52R&D Systems
See all sources

Pathways related to Polycythemia according to GeneCards/GeneDecks:

(show top 50)    (show all 56)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.8PPBP, JAK2, STAT5A, ITGB3, IL3, TIMP1
210.8JAK2, PTPN6, IL3, EPO, IFNA2, MPL
3
Hide members
10.8PPBP, THPO, TIMP1, JAK2, STAT5A, ITGB3
4
Hide members
10.8THPO, TIMP1, ITGB3, STAT5A, EPOR, JAK2
5
Hide members
10.8IFNA2, PPBP, TIMP1, JAK2, ITGB3, MPL
6
Hide members
10.8STAT5A, MPL, EPOR, IL3, JAK2, PPBP
7
Hide members
10.8PTPN6, IL3, TIMP1, PPBP, JAK2, KITLG
810.7IFNA2, KITLG, IL3, EPOR, EPO, ITGB3
9
Hide members
10.7PPBP, ITGB3, TIMP1, EPOR, IL3, THPO
1010.7THPO, ITGB3, EPO, EPOR, IL3, KITLG
11
Hide members
10.7EPO, STAT5A, JAK2, EPOR, PTPN6, ITGB3
12
Hide members
10.7PTPN6, JAK2, KITLG, EPOR, STAT5A, EPO
13
Development EPO-induced Jak-STAT pathway
Hide members
10.7EPOR, STAT5A, JAK2, SOCS3, EPO, PTPN6
14
Development Thrombopoetin signaling via JAK-STAT pathway
Hide members
10.7STAT5A, MPL, JAK2, SOCS3, PTPN6, THPO
15
Hide members
10.7IL3, TIMP1, EPOR, THPO, KITLG, PPBP
16
Hide members
10.7EPOR, PPBP, TIMP1, IL3, THPO, KITLG
17
Hide members
10.7THPO, KITLG, IL3, PPBP, TIMP1, EPOR
18
Hide members
10.7TIMP1, PPBP, IL3, KITLG, THPO, ITGB3
19
Hide members
10.7MPL, SOCS3, TIMP1, ITGB3, THPO, PPBP
20
Hide members
10.7PTPN6, IL3, STAT5A, JAK2, IFNA2, SOCS3
21
Hide members
10.7KITLG, JAK2, ITGB3, EPOR, EPO
22
Hide members
10.7THPO, KITLG, IL3, JAK2, PPBP
23
Hide members
10.7THPO, MPL, STAT5A, JAK2, SOCS3
2410.7JAK2, STAT5A, ITGB3, SOCS3, PTPN6
2510.7SOCS3, STAT5A, JAK2, IL3, PTPN6
26
Hide members
10.7JAK2, STAT5A, PTPN6, IL3, SOCS3
27
Immune response IL-2 activation and signaling pathway
Hide members
10.7SOCS3, JAK2, STAT5A, IL3, PTPN6
28
Hide members
10.6JAK2, KITLG, PTPN6, STAT5A
2910.6STAT5A, PTPN6, JAK2, SOCS3
3010.6SOCS3, JAK2, STAT5A, PTPN6
31
Hide members
10.6JAK2, SOCS3, STAT5A, PTPN6
3210.6JAK2, STAT5A, ITGB3, SOCS3
33
Hide members
10.6THPO, KITLG, PPBP, TIMP1
34
Development PDGF signaling via STATs and NF-kB
Hide members
10.6TIMP1, SOCS3, JAK2, STAT5A
35
Immune response Oncostatin M signaling via JAK-Stat in human cells
Hide members
10.6JAK2, SOCS3, TIMP1, STAT5A
36
Hide members
10.6PF4, STAT5A, JAK2, PPBP
37
Hide members
10.6ITGB3, PF4, PPBP, TIMP1
3810.6JAK2, EPO, EPOR
39
Hide members
10.6MPL, THPO, ITGB3
4010.6PTPN6, SOCS3, JAK2
4110.6PTPN6, STAT5A, JAK2
4210.6PTPN6, STAT5A, JAK2
4310.6ITGB3, PTPN6, VHL
4410.6TIMP1, SOCS3, JAK2
45
Development Leptin signaling via JAK/STAT and MAPK cascades
Hide members
10.6SOCS3, TIMP1, JAK2
4610.6TIMP1, ITGB3, VHL
4710.6JAK2, SOCS3, IFNA2
4810.6SOCS3, JAK2, STAT5A
4910.6STAT5A, SOCS3, JAK2
50
Immune response IFN alpha/beta signaling pathway
Hide members
10.6IFNA2, SOCS3, PTPN6

Compounds for genes affiliated with Polycythemia

About this section
Sources:
44Novoseek, 24HMDB, 49PharmGKB, 28IUPHAR, 11DrugBank, 59Tocris Bioscience, 2BitterDB
See all sources

Compounds related to Polycythemia according to GeneCards/GeneDecks:

(show top 50)    (show all 157)
idCompoundScoreTop Affiliating Genes
1tyrosine4411.6EPOR, PF4, IL3, KITLG, THPO, ACP1
2vegf4411.4PTPN6, ACP1, THPO, TIMP1, VHL, IFNA2
3phosphatidylinositol4411.4KITLG, IL3, EPOR, EPO, MPL, STAT5A
4alanine4411.4PTPN6, TIMP1, IFNA2, ACP1, THPO, KITLG
5cysteine4411.4EPOR, PF4, IL3, THPO, ACP1, PTPN6
6gp 1304411.3TIMP1, PTPN6, THPO, KITLG, IL3, EPOR
7thymidine44 2412.3PPBP, IFNA2, JAK2, STAT5A, EPOR, PF4
8agar4411.3JAK2, STAT5A, G6PD, EPOR, PF4, IL3
9ly2940024411.3EPO, THPO, IL3, KITLG, ACP1, EPOR
105-aza-2deoxycytidine4411.2EPO, JAK2, TIMP1, VHL, SOCS3, IL3
11aspirin44 49 28 2414.2ITGB3, G6PD, PF4, TIMP1, PPBP, KITLG
12rapamycin4411.2STAT5A, EPO, IL3, THPO, ACP1, JAK2
13hydroxyurea44 49 1113.2THPO, PF4, EPO, KITLG, JAK2, PPBP
14nitric oxide44 11 2413.2PTPN6, TIMP1, VHL, KITLG, EPOR, STAT5A
15serine4411.2MPL, EPOR, PTPN6, JAK2, G6PD, TIMP1
16lysine4411.2VHL, JAK2, IFNA2, SOCS3, ITGB3, MPL
17cisplatin44 49 59 1114.2ACP1, IFNA2, G6PD, JAK2, EPO, TIMP1
18lipid4411.2STAT5A, JAK2, PPBP, G6PD, IFNA2, PF4
19anagrelide44 1112.1PF4, EPO, MPL, JAK2, IFNA2, THPO
20oxygen44 2412.1PF4, EPOR, VHL, STAT5A, EPO, JAK2
21epinephrine44 11 2413.1ACP1, THPO, IFNA2, G6PD, KITLG, PF4
22cytarabine44 49 1113.1THPO, EPO, IL3, IFNA2, STAT5A, KITLG
23wortmannin4411.1IL3, KITLG, PF4, EPOR, JAK2, STAT5A
24actinomycin d4411.1TIMP1, VHL, G6PD, JAK2, IL3, THPO
25glucose4411.1SOCS3, IFNA2, KITLG, PPBP, PTPN6, PF4
26methylcellulose4411.1KITLG, TIMP1, IL3, EPOR, EPO, THPO
27herbimycin a44 5912.1JAK2, IL3, KITLG, ACP1, PTPN6, TIMP1
28genistein44 28 59 2 11 2416.1IL3, ACP1, THPO, KITLG, STAT5A, JAK2
29ribavirin44 49 1113.1IFNA2, SOCS3, G6PD, EPO, IL3, TIMP1
30pixy3214411.1IL3, KITLG, THPO, TIMP1, EPO
31iron44 2412.1KITLG, THPO, VHL, IFNA2, ITGB3, MPL
32filgrastim44 1112.0THPO, EPO, IL3, KITLG, IFNA2
33polyethylene glycol4411.0THPO, IFNA2, PF4, MPL, G6PD, KITLG
34lactate4411.0TIMP1, THPO, KITLG, IL3, PF4, G6PD
35aspartate4411.0JAK2, G6PD, STAT5A, ACP1, PTPN6
36phosphotyrosine4411.0SOCS3, JAK2, PTPN6, ACP1, IL3, EPOR
37etoposide44 49 59 1114.0TIMP1, ACP1, THPO, IL3, PF4, STAT5A
38estrogen4411.0THPO
39imatinib44 49 1112.9IL3, EPO, STAT5A, JAK2, KITLG, THPO
40gm-csf44 2811.9STAT5A, THPO
41histamine44 28 2412.9TIMP1, KITLG, IL3, THPO, PF4, PPBP
42amifostine44 1111.8KITLG, EPO, THPO, IL3
43h2o24410.8G6PD, PTPN6, THPO, KITLG, IL3, JAK2
44prostacyclin4410.8ACP1, PPBP, THPO, IL3, TIMP1, PF4
45butyrate4410.8JAK2, THPO, ACP1
46indomethacin44 59 28 1113.8PF4, ACP1
47cyclosporin a44 28 5912.7JAK2, ACP1, TIMP1, KITLG, IL3, EPO
48retinoic acid44 2411.7TIMP1, IFNA2, ACP1, PTPN6, STAT5A, IL3
49carboplatin44 49 1112.7THPO, IFNA2, IL3, EPO, KITLG
505fluorouracil4410.4MPL, PF4, IL3, IFNA2, KITLG, THPO

GO Terms for genes affiliated with Polycythemia

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Polycythemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00561510.6THPO, IFNA2, PPBP, EPO, PF4, IL3
2platelet alpha granule lumenGO:03109310.6PF4, PPBP, TIMP1
3extracellular regionGO:00557610.5TIMP1, IFNA2, PPBP, EPO, EPOR, PF4

Biological processes related to Polycythemia according to GeneCards/GeneDecks:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1blood coagulationGO:00759611.2PTPN6, TIMP1, IFNA2, PPBP, JAK2, ITGB3
2platelet activationGO:03016811.0TIMP1, PPBP, ITGB3, MPL, PF4, THPO
3JAK-STAT cascade involved in growth hormone signaling pathwayGO:06039710.9SOCS3, JAK2, STAT5A, PTPN6
4positive regulation of peptidyl-tyrosine phosphorylationGO:05073110.9JAK2, ITGB3, IL3, KITLG
5cytokine-mediated signaling pathwayGO:01922110.9IFNA2, SOCS3, JAK2, PF4, PTPN6
6erythrocyte maturationGO:04324910.9EPO, G6PD, TIMP1
7regulation of interferon-gamma-mediated signaling pathwayGO:06033410.9SOCS3, JAK2, PTPN6
8platelet degranulationGO:00257610.9PF4, ITGB3, PPBP, TIMP1
9positive regulation of tyrosine phosphorylation of Stat5 proteinGO:04252310.9JAK2, EPO, IL3
10positive regulation of cell differentiationGO:04559710.8JAK2, SOCS3, VHL
11JAK-STAT cascadeGO:00725910.8STAT5A, JAK2, SOCS3
12regulation of type I interferon-mediated signaling pathwayGO:06033810.8IFNA2, SOCS3, PTPN6
13positive regulation of cell proliferationGO:00828410.7PTPN6, IL3, EPO, JAK2, TIMP1
14negative regulation of mast cell apoptotic processGO:03302610.7KITLG, STAT5A
15positive regulation of DNA replicationGO:04574010.7EPO, IL3, KITLG
16positive regulation of mast cell proliferationGO:07066810.7KITLG, STAT5A
17peptidyl-tyrosine phosphorylationGO:01810810.6JAK2, STAT5A, PTPN6
18type I interferon-mediated signaling pathwayGO:06033710.6PTPN6, SOCS3, IFNA2
19mammary gland epithelium developmentGO:06118010.4STAT5A, JAK2
20interferon-gamma-mediated signaling pathwayGO:06033310.3PTPN6, JAK2, SOCS3

Molecular functions related to Polycythemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00551510.9VHL, IFNA2, SOCS3, G6PD, JAK2, STAT5A
2growth factor activityGO:00808310.5THPO, KITLG, IL3, PPBP
3cytokine activityGO:00512510.3IFNA2, IL3, KITLG, THPO

Products for genes affiliated with Polycythemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Polycythemia

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet